Hanson & Doremus Investment Management Maintains Position in Cigna Corporation (NYSE:CI)

Hanson & Doremus Investment Management maintained its position in shares of Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent filing with the SEC. The firm owned 817 shares of the health services provider’s stock at the end of the second quarter. Hanson & Doremus Investment Management’s holdings in Cigna Corporation were worth $137,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Guardian Life Insurance Co. of America increased its stake in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares during the period. Bronfman E.L. Rothschild L.P. increased its stake in shares of Cigna Corporation by 1.1% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock worth $309,000 after buying an additional 22 shares during the period. Boys Arnold & Co. Inc. increased its stake in shares of Cigna Corporation by 1.8% in the first quarter. Boys Arnold & Co. Inc. now owns 1,833 shares of the health services provider’s stock worth $269,000 after buying an additional 33 shares during the period. Winslow Evans & Crocker Inc. increased its stake in shares of Cigna Corporation by 1.9% in the second quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock worth $304,000 after buying an additional 34 shares during the period. Finally, IFP Advisors Inc increased its stake in shares of Cigna Corporation by 1.9% in the first quarter. IFP Advisors Inc now owns 2,180 shares of the health services provider’s stock worth $319,000 after buying an additional 41 shares during the period. Institutional investors own 86.91% of the company’s stock.

Shares of Cigna Corporation (CI) traded down 0.56% on Friday, reaching $174.38. 1,174,009 shares of the company’s stock were exchanged. The company’s 50 day moving average price is $172.22 and its 200-day moving average price is $159.17. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $178.57. The stock has a market cap of $43.91 billion, a P/E ratio of 20.12 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last released its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same period in the previous year, the company posted $1.98 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities analysts forecast that Cigna Corporation will post $10.02 EPS for the current fiscal year.

WARNING: “Hanson & Doremus Investment Management Maintains Position in Cigna Corporation (NYSE:CI)” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://stocknewstimes.com/2017/08/12/cigna-corporation-nyseci-position-maintained-by-hanson-doremus-investment-management-updated.html.

A number of equities analysts have recently commented on CI shares. Zacks Investment Research raised shares of Cigna Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, April 18th. Jefferies Group LLC reaffirmed a “buy” rating and set a $178.00 price objective (up from $172.00) on shares of Cigna Corporation in a report on Sunday, April 23rd. Stifel Nicolaus increased their target price on shares of Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, May 5th. Royal Bank Of Canada increased their target price on shares of Cigna Corporation from $172.00 to $177.00 and gave the stock an “outperform” rating in a research report on Monday, May 8th. Finally, Deutsche Bank AG increased their target price on shares of Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, May 10th. Three equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $180.06.

In related news, EVP Nicole S. Jones sold 20,312 shares of the company’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total transaction of $3,250,732.48. Following the completion of the sale, the executive vice president now owns 44,737 shares in the company, valued at $7,159,709.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michael W. Triplett sold 1,439 shares of the company’s stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $166.89, for a total value of $240,154.71. Following the sale, the insider now owns 26,199 shares of the company’s stock, valued at approximately $4,372,351.11. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 261,539 shares of company stock worth $44,527,348. Corporate insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply